Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

December 31, 2025

Conditions
Condylomata Acuminata
Interventions
DRUG

Peginterferon α-2b injection

Participants receive CO2 laser treatment followed by local injection of 36mcg of Peginterferon α-2b directly into the base of each treated wart, repeated weekly for 12 weeks, and then followed for another 12 weeks.

DRUG

Peginterferon α-2b injection

Participants undergo CO2 laser treatment and then receive a weekly subcutaneous injection of 180mcg of Peginterferon α-2b for 12 weeks, and then followed for another 12 weeks.

OTHER

CO2 laser

On the day (baseline), CO2 laser treatment was performed to remove all warts, and the treatment range was 0.2cm around the lesion and the depth was up to the dermis. Wound disinfection after laser. Participants are treated with CO2 laser therapy only and are observed for 12 weeks, followed by another 12-week observation period without any additional adjuvant therapy.

Trial Locations (1)

310006

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors
lead

Zhangyu Bu

OTHER

NCT06430190 - Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata | Biotech Hunter | Biotech Hunter